Jung Eujene, Ro Young Sun, Song Kyoung Jun, Shin Sang Do, Ryu Hyun Ho
Department of Emergency Medicine, Chonnam National University Medical School, Jeollanamdo 58128, Republic of Korea.
Department of Emergency Medicine, Seoul National University, Seoul 03080, Republic of Korea.
J Clin Med. 2025 Apr 22;14(9):2867. doi: 10.3390/jcm14092867.
: Current guidelines recommend fluid resuscitation only for out-of-hospital cardiac arrest (OHCA) patients with hypovolemia. This study aimed to determine whether intravenous (IV) fluid resuscitation improves survival outcomes of OHCA patients and how fluid resuscitation is influenced by the emergency medical service (EMS)-treated time interval (ETI), including scene time interval and transport time interval. : EMS-treated OHCA adult patients with presumed cardiac etiology were enrolled between 2018 and 2019. The main exposure was IV fluid resuscitation by an EMS provider during transportation. The main outcomes were survival to discharge and neurological recovery. Multivariable logistic regression analysis calculated adjusted odd ratios (aORs). Interaction analysis between IV fluid resuscitation and ETI was also performed. : Of 29,228 eligible patients, 13,683 (46.8%) patients received IV fluid resuscitation. Patients receiving IV fluid resuscitation had a significantly higher likelihood of survival to discharge (aOR [95% confidence interval, CI]: 1.15 [1.01-1.32]). Considering the interaction effects between IV fluid resuscitation and ETI for survival to discharge, aOR (95% CI) was 1.20 (1.02-1.43) for patients with an ETI > 16 min and <30 min and 1.48 (1.09-2.01) for patients with an ETI of >31 min ( for interaction <0.01) compared to ETI < 15 min, used as a reference. : IV fluid resuscitation improved survival to discharge in OHCA patients, and this benefit was maintained only with the ETI > 16 min.
当前指南建议仅对低血容量的院外心脏骤停(OHCA)患者进行液体复苏。本研究旨在确定静脉(IV)液体复苏是否能改善OHCA患者的生存结局,以及液体复苏如何受到紧急医疗服务(EMS)治疗时间间隔(ETI)的影响,包括现场时间间隔和转运时间间隔。:2018年至2019年期间纳入了病因推测为心脏原因的接受EMS治疗的OHCA成年患者。主要暴露因素是EMS提供者在转运过程中进行的IV液体复苏。主要结局是出院生存和神经功能恢复。多变量逻辑回归分析计算调整后的比值比(aORs)。还进行了IV液体复苏与ETI之间的交互分析。:在29228名符合条件的患者中,13683名(46.8%)患者接受了IV液体复苏。接受IV液体复苏的患者出院生存的可能性显著更高(aOR [95%置信区间,CI]:1.15 [1.01 - 1.32])。考虑到IV液体复苏与ETI对出院生存的交互作用,与作为参考的ETI < 15分钟相比,ETI > 16分钟且<30分钟的患者aOR(95% CI)为1.20(1.02 - 1.43),ETI > 31分钟的患者为1.48(1.09 - 2.01)(交互作用P < 0.01)。:IV液体复苏改善了OHCA患者的出院生存率,且仅在ETI > 16分钟时这种益处得以维持。